420 related articles for article (PubMed ID: 33390845)
1. Long Non-Coding RNAs: Potential Biomarkers and Targets for Hepatocellular Carcinoma Therapy and Diagnosis.
Yuan D; Chen Y; Li X; Li J; Zhao Y; Shen J; Du F; Kaboli PJ; Li M; Wu X; Ji H; Cho CH; Wen Q; Li W; Xiao Z; Chen B
Int J Biol Sci; 2021; 17(1):220-235. PubMed ID: 33390845
[TBL] [Abstract][Full Text] [Related]
2. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment.
Shi T; Morishita A; Kobara H; Masaki T
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638971
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
Qiu L; Tang Q; Li G; Chen K
Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
[TBL] [Abstract][Full Text] [Related]
4. Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma.
Yao Z; Jia C; Tai Y; Liang H; Zhong Z; Xiong Z; Deng M; Zhang Q
Aging (Albany NY); 2020 Jun; 12(12):11843-11863. PubMed ID: 32554864
[TBL] [Abstract][Full Text] [Related]
5. Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV.
Lu J; Xie F; Geng L; Shen W; Sui C; Yang J
Tumour Biol; 2015 May; 36(5):3231-6. PubMed ID: 25501706
[TBL] [Abstract][Full Text] [Related]
6. The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis.
Yu J; Han J; Zhang J; Li G; Liu H; Cui X; Xu Y; Li T; Liu J; Wang C
Medicine (Baltimore); 2016 Aug; 95(31):e4436. PubMed ID: 27495068
[TBL] [Abstract][Full Text] [Related]
7. Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma.
Xie H; Ma H; Zhou D
Biomed Res Int; 2013; 2013():136106. PubMed ID: 23762823
[TBL] [Abstract][Full Text] [Related]
8. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma.
Kamel MM; Matboli M; Sallam M; Montasser IF; Saad AS; El-Tawdi AHF
Transl Res; 2016 Feb; 168():134-145. PubMed ID: 26551349
[TBL] [Abstract][Full Text] [Related]
9. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
Hou W; Bonkovsky HL
World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
[TBL] [Abstract][Full Text] [Related]
10. LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway.
Wang X; Zhang W; Tang J; Huang R; Li J; Xu D; Xie Y; Jiang R; Deng L; Zhang X; Chai Y; Qin X; Sun B
Cell Death Dis; 2016 Mar; 7(3):e2130. PubMed ID: 26938303
[TBL] [Abstract][Full Text] [Related]
11. lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma.
Chao Y; Zhou D
Med Sci Monit; 2019 Sep; 25():6581-6586. PubMed ID: 31475695
[TBL] [Abstract][Full Text] [Related]
12. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
13. Circulating LncRNAs Serve as Diagnostic Markers for Hepatocellular Carcinoma.
Yuan W; Sun Y; Liu L; Zhou B; Wang S; Gu D
Cell Physiol Biochem; 2017; 44(1):125-132. PubMed ID: 29130980
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of plasma lncRNA small nucleolar RNA host gene 1 in patients with hepatocellular carcinoma.
Gao S; Xu X; Wang Y; Zhang W; Wang X
Mol Med Rep; 2018 Sep; 18(3):3305-3313. PubMed ID: 30066898
[TBL] [Abstract][Full Text] [Related]
16. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
[TBL] [Abstract][Full Text] [Related]
17. Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma.
El-Tawdi AH; Matboli M; El-Nakeep S; Azazy AE; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):869-77. PubMed ID: 27215316
[TBL] [Abstract][Full Text] [Related]
18. The role of long noncoding RNAs in hepatocellular carcinoma.
Huang Z; Zhou JK; Peng Y; He W; Huang C
Mol Cancer; 2020 Apr; 19(1):77. PubMed ID: 32295598
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNAs in hepatocellular carcinoma: Ordering of the complicated lncRNA regulatory network and novel strategies for HCC clinical diagnosis and treatment.
Li C; Yang J; Liu C; Wang X; Zhang L
Pharmacol Res; 2020 Aug; 158():104848. PubMed ID: 32389858
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.
Niu ZS; Niu XJ; Wang WH
World J Gastroenterol; 2017 Aug; 23(32):5860-5874. PubMed ID: 28932078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]